Mettler-Toledo International (NYSE:MTD) Upgraded at Evercore ISI

Evercore ISI upgraded shares of Mettler-Toledo International (NYSE:MTD) from an in-line rating to an outperform rating in a report published on Thursday, Marketbeat Ratings reports. Evercore ISI currently has $1,450.00 price target on the medical instruments supplier’s stock, up from their previous price target of $1,375.00.

Other research analysts have also recently issued research reports about the company. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their target price for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Robert W. Baird lowered their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Finally, Wells Fargo & Company dropped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Trading Up 1.4 %

Shares of Mettler-Toledo International stock opened at $1,238.28 on Thursday. The company’s fifty day simple moving average is $1,256.98 and its two-hundred day simple moving average is $1,356.20. Mettler-Toledo International has a 12-month low of $1,115.64 and a 12-month high of $1,546.93. The company has a market cap of $26.13 billion, a P/E ratio of 33.39, a PEG ratio of 4.21 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Analysts predict that Mettler-Toledo International will post 40.42 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

A number of large investors have recently added to or reduced their stakes in the stock. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International during the second quarter valued at $42,000. TD Asset Management Inc lifted its stake in shares of Mettler-Toledo International by 1.9% in the 2nd quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock worth $219,767,000 after purchasing an additional 2,866 shares during the period. National Bank of Canada FI boosted its holdings in shares of Mettler-Toledo International by 14.7% in the second quarter. National Bank of Canada FI now owns 6,956 shares of the medical instruments supplier’s stock worth $9,507,000 after buying an additional 894 shares during the last quarter. Kornitzer Capital Management Inc. KS grew its position in Mettler-Toledo International by 3.7% during the second quarter. Kornitzer Capital Management Inc. KS now owns 2,697 shares of the medical instruments supplier’s stock valued at $3,769,000 after buying an additional 96 shares during the period. Finally, Torray Investment Partners LLC increased its holdings in Mettler-Toledo International by 8.5% during the second quarter. Torray Investment Partners LLC now owns 1,351 shares of the medical instruments supplier’s stock valued at $1,888,000 after buying an additional 106 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.